Coleman SpA, through the Medicina Futura brand, operates in the health care services sector under an accreditation scheme with the NHS. The company is active with 9 multi-specialty and clinical-surgical diagnostic facilities located in the province of Naples.
Since 2015 Coleman has implemented an industrial expansion strategy, with investments in the purchase of a rehabilitation clinic in Rome and in the implementation of a new diagnostic center in Dubai. Due to the high CapEx exceeding expectations and the difficult economic situation, Coleman experienced a situation of liquidity tension that led to the abandonment of the Dubai initiative and globally affected the company's operations.
In the corporate turnaround process, which involved the structuring and execution of a relaunch plan under Art. 67 LF, Coleman SpA was assisted by Enrico Scoditti of Hybris Corporate Finance and Massimo Carnicella of Hill House Capital for the finance component and by Gabriella Covino by Gianni & Origoni for the legal part.
Coleman, therefore, rescheduled the debt exposure, for a total amount of EUR 53m, through the sale of non-strategic assets and the long-term write-off/rescheduling of part of the commercial and financial debt.